Non-Opioid Pain Treatment Market By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids and Others), By Application (Neuropathic Pain, Chronic Pain, Post-operative Pain and Acute Pain), By Route of Administration (Oral, Topical, Injectable and Other Route of Administration), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: June 2025
- Report ID: 151641
- Number of Pages: 326
- Format:
-
keyboard_arrow_up
-
-
- Novartis AG Company Profile
- Teva Pharmaceutical Industries Ltd. Company Profile
- Dr. Reddys Laboratories Ltd Company Profile
- Sun Pharmaceutical Industries Ltd.
- GSK plc
- Pfizer Inc Company Profile
- Perrigo Company plc
- Cipla Limited Company Profile
- Johnson & Johnson Services, Inc.
- Pacira Pharmaceuticals, Inc.
- Pierrel S.p.A.
- Vertex Pharmaceuticals
- Assertio Therapeutics
- Mylan N.V. (Viatris)
- Flexion Therapeutics
- Other Key Players
- settingsSettings
Our Clients
- 151641
- June 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
